Secukinumab
Secukinumab is a human interleukin-17A antagonist indicated for the treatment of:
- Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy
- Adults with active psoriatic arthritis (PsA)
- Adults with active ankylosing spondylitis (AS)
There are no products to list in this category.
-300x43.png "Biomed Pharmacy"){kind=small}